JW Cayman Therapeutics Files Director List with HKEX

Reuters

2025/12/12

JW Cayman <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Files Director List with HKEX

JW (Cayman) Therapeutics Co. Ltd. has filed an updated list of directors and their roles to the Hong Kong Stock Exchange. The Board comprises Dr. Cheng Liu (Chairman), Dr. Yiping James Li, Ms. Xing Gao, and Dr. Sungwon Song as Non-executive Directors, alongside Independent Non-executive Directors Mr. Kin Cheong Kelvin Ho, Dr. Debra Yu, and Mr. Peng Kuan Chan. Committee memberships were also disclosed: Mr. Ho serves as Chairman of both the Audit and Nomination Committees, with Dr. Yu chairing the Remuneration and Business Development and Strategy Committees. Ms. Gao and Mr. Chan are members of the Audit Committee, while Dr. Song is a member of the Remuneration Committee. Dr. Yu and Ms. Gao are members of the Business Development and Strategy Committee and Remuneration Committee, respectively.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JW Cayman Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251212-11953206), on December 11, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2590476205"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2590476205\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2590476205?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 07:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590476205","market":"us","top_or_hot":-1,"title":"JW Cayman Therapeutics Files Director List with HKEX","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      JW Cayman <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Files Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        JW (Cayman) Therapeutics Co. Ltd. has filed an updated list of directors and their roles to the Hong Kong Stock Exchange. The Board comprises Dr. Cheng Liu (Chairman), Dr. Yiping James Li, Ms. Xing Gao, and Dr. Sungwon Song as Non-executive Directors, alongside Independent Non-executive Directors Mr. Kin Cheong Kelvin Ho, Dr. Debra Yu, and Mr. Peng Kuan Chan. Committee memberships were also disclosed: Mr. Ho serves as Chairman of both the Audit and Nomination Committees, with Dr. Yu chairing the Remuneration and Business Development and <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> Committees. Ms. Gao and Mr. Chan are members of the Audit Committee, while Dr. Song is a member of the Remuneration Committee. Dr. Yu and Ms. Gao are members of the Business Development and <a href=\"https://laohu8.com/S/STRF\">Strategy</a> Committee and Remuneration Committee, respectively.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JW Cayman Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251212-11953206), on December 11, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JW Cayman Therapeutics Files Director List with HKEX</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJW Cayman Therapeutics Files Director List with HKEX\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-12 07:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      JW Cayman <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Files Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        JW (Cayman) Therapeutics Co. Ltd. has filed an updated list of directors and their roles to the Hong Kong Stock Exchange. The Board comprises Dr. Cheng Liu (Chairman), Dr. Yiping James Li, Ms. Xing Gao, and Dr. Sungwon Song as Non-executive Directors, alongside Independent Non-executive Directors Mr. Kin Cheong Kelvin Ho, Dr. Debra Yu, and Mr. Peng Kuan Chan. Committee memberships were also disclosed: Mr. Ho serves as Chairman of both the Audit and Nomination Committees, with Dr. Yu chairing the Remuneration and Business Development and <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> Committees. Ms. Gao and Mr. Chan are members of the Audit Committee, while Dr. Song is a member of the Remuneration Committee. Dr. Yu and Ms. Gao are members of the Business Development and <a href=\"https://laohu8.com/S/STRF\">Strategy</a> Committee and Remuneration Committee, respectively.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JW Cayman Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251212-11953206), on December 11, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL8HV5Jx:1","article_id":"2590476205","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590476205","pubTimestamp":1765496054,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"JW  Therapeutics Co. Ltd. has filed an updated list of directors and their roles to the Hong Kong Stock Exchange. The Board comprises Dr. Cheng Liu , Dr. Yiping James Li, Ms. Xing Gao, and Dr. Sungwon Song as Non-executive Directors, alongside Independent Non-executive Directors Mr. Kin Cheong Kelvin Ho, Dr. Debra Yu, and Mr. Peng Kuan Chan. Committee memberships were also disclosed: Mr. Ho serves as Chairman of both the Audit and Nomination Committees, with Dr. Yu chairing the Remuneration and Business Development and Strategy Committees. Ms. Gao and Mr. Chan are members of the Audit Committee, while Dr. Song is a member of the Remuneration Committee. Dr. Yu and Ms. Gao are members of the Business Development and Strategy Committee and Remuneration Committee, respectively.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1583":"高瓴概念","BK1574":"生物医药B类股","BK1161":"生物科技","02126":"药明巨诺-B"},"translate_title":"JW Cayman Therapeutics向港交所提交董事名单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02126":0.9},"content_text":"JW Cayman Therapeutics Files Director List with HKEX\n    \n\n        JW (Cayman) Therapeutics Co. Ltd. has filed an updated list of directors and their roles to the Hong Kong Stock Exchange. The Board comprises Dr. Cheng Liu (Chairman), Dr. Yiping James Li, Ms. Xing Gao, and Dr. Sungwon Song as Non-executive Directors, alongside Independent Non-executive Directors Mr. Kin Cheong Kelvin Ho, Dr. Debra Yu, and Mr. Peng Kuan Chan. Committee memberships were also disclosed: Mr. Ho serves as Chairman of both the Audit and Nomination Committees, with Dr. Yu chairing the Remuneration and Business Development and Strategy Committees. Ms. Gao and Mr. Chan are members of the Audit Committee, while Dr. Song is a member of the Remuneration Committee. Dr. Yu and Ms. Gao are members of the Business Development and Strategy Committee and Remuneration Committee, respectively.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JW Cayman Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251212-11953206), on December 11, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}